In our study, we demonstrated that METTL13, a regulator of translation elongation, showed higher expression levels in HNSCC tumors than adjacent normal tissues and might serve as a prognostic marker for overall survival in HNSCC patients. This evidence concerns the gene METTL13 and head and neck squamous cell carcinoma.